X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

期刊標題檢索 CRIT REV ONCOL 最新評論: May I ask about the follow-up results? Has the status changed? I have... (2025-08-31)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY]您好,您是該頁面的第 38508 位訪客。

期刊簡介
期刊名稱CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
LetPub Score
7.5
50 ratings
Rate

Reputation
8.7

Influence
6.7

Speed
6.9

期刊簡稱CRIT REV ONCOL HEMAT
ISSN1040-8428
E-ISSN1879-0461
h-index111
CiteScore
CiteScoreSJRSNIPCiteScore Rank
10.401.8201.403
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Geriatrics and Gerontology
Q18 / 120
Category: Medicine
Subcategory: Hematology
Q116 / 142
Category: Medicine
Subcategory: Oncology
Q155 / 415

自引率 (2023-2024)1.80%自引率趨勢
掲載範囲
Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.
官方網站http://www.croh-online.com/
在線稿件提交http://ees.elsevier.com/croh
開放訪問No
出版商Elsevier Ireland Ltd
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1983
每年文章數264每年文章數趨勢
黃金OA百分比29.21%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
HEMATOLOGYSCIEQ115/98
ONCOLOGYSCIEQ157/326
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1040-8428%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
來自Elsevier的數據: Average 27.3 Week(s)
競爭力 *來自作者的數據: Ordinary
來自Elsevier的數據: 83%
在線文章發布時間來自Elsevier的數據: Average 8.8 Week(s)
參考鏈接
相關期刊 【CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal of Hematology & OncologyH-index: 60

    CiteScore: 57.90
    BLOODH-index: 426

    CiteScore: 23.00
    LEUKEMIAH-index: 176

    CiteScore: 18.50
    AMERICAN JOURNAL OF HEMATOLOGYH-index: 92

    CiteScore: 13.60
    HAEMATOLOGICAH-index: 125

    CiteScore: 11.30
    BLOOD REVIEWSH-index: 85

    CiteScore: 15.00
    BRITISH JOURNAL OF HAEMATOLOGYH-index: 172

    CiteScore: 7.40
    SEMINARS IN HEMATOLOGYH-index: 88

    CiteScore: 6.60
    HEMATOLOGICAL ONCOLOGYH-index: 42

    CiteScore: 4.90
    CURRENT OPINION IN HEMATOLOGYH-index: 90

    CiteScore: 5.60
    學科內最受檢索的期刊 頁面查看次數
    BLOOD128499
    Journal of Hematology & Oncology105174
    BRITISH JOURNAL OF HAEMATOLOGY69295
    LEUKEMIA61552
    ANNALS OF HEMATOLOGY59831
    Hematology50527
    LEUKEMIA & LYMPHOMA46572
    AMERICAN JOURNAL OF HEMATOLOGY39011
    LEUKEMIA RESEARCH36247
    HAEMATOLOGICA29720
  •  

    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY] 的評論撰寫評論
作者: 刘昕澜


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-31 09:22:31 評論於
May I ask about the follow-up results? Has the status changed? I have been waiting for nearly a month now, and I have emailed both the chief editor and the editors, but there has been no response.
(0) 讚! | 刘昕澜

作者: 11jj


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-08-23 09:54:15 評論於
I submitted on July 26th, and the whole process was very fast. If it takes two months, you can follow up to push for the manuscript. I previously submitted to an Elsevier journal and the external review took a long time. I contacted Elsevier's customer service to help me push the editor, and a few days later it was decided.
(0) 讚! | 11jj

作者: recept


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-23 09:47:03 評論於
Hello, how is everything going?
(0) 讚! | recept

作者: recept


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-23 09:45:33 評論於
Just saw the submission time on another post. In this case, can we ask the editor to hurry up the submission?
(0) 讚! | recept

作者: recept


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-23 09:37:49 評論於
Hello, I would like to know when you submitted your application? It has been two months and I have not received any updates, my messages are not being replied to.
(0) 讚! | recept

作者: 11jj


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-08-22 21:57:53 評論於
Six people reviewed the manuscript in the first round, but when two of them came back with their opinions, the editors decided to make major revisions, causing a delay that lasted for a day.
(0) 讚! | 11jj

作者: 施景龙 SHI


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-20 23:41:39 評論於
May I ask how many people are reviewing the first round, and have you experienced a dip before?
(0) 讚! | 施景龙 SHI

作者: 11jj


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-08-19 14:13:01 評論於
Immunotherapy for tumors.
(0) 讚! | 11jj

作者: 刘昕澜


領域: 医学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-15 23:50:01 評論於
Hello! May I ask which sector's overview did you invest in?
(0) 讚! | 刘昕澜

作者: 施景龙 SHI


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-15 19:19:36 評論於
What direction are you writing in? Is it a summary?
(0) 讚! | 施景龙 SHI

作者: 施景龙 SHI


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-15 19:18:15 評論於
What direction are you writing in? Can I ask?
(0) 讚! | 施景龙 SHI

作者: 11jj


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-08-14 15:03:18 評論於
A very pleasant submission experience. The first time encountering such a fast process (unbelievable)
7.26 Submit to the journal
7.29 With editor
7.29 Under Review
8.1 RRC
8.1 Major revision
8.5 Revision submit
8.7 RRC
8.7 Accept
8.8 Online
(0) 讚! | 11jj

作者: recept


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-11 08:45:29 評論於
The speed is too slow, it has been over a month and I have sent three letters but received no response.
(0) 讚! | recept

作者: 吡啡尼酮


領域: 医学
審稿時間: 12.0 month(s)
結果: 修改後接受


撰寫評論

2025-01-02 13:45:41 評論於
With editor for 2 months, under review for 6 months, still unable to find reviewers. Major revisions at 9 months. Accepted after minor revisions at 11 months. Please consider carefully if urgent.
(0) 讚! | 吡啡尼酮

作者: 鑫钰baby


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-15 15:21:18 評論於
Research focus: tumors; sharing experiences with solid tumors: Where did the magazine editor go? No news for two months with the editor.
(0) 讚! | 鑫钰baby

作者: 碧水傲文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-28 10:41:04 評論於
How did you find the email address of the editor-in-chief?
(0) 讚! | 碧水傲文

作者: 无妄迎真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-25 13:17:22 評論於
Is there any news now?
(0) 讚! | 无妄迎真

作者: 百花梦竹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-29 14:11:11 評論於
Focused research direction: tumor experience sharing: Submitted on December 15th, still with editor
(0) 讚! | 百花梦竹

作者: MW小白


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 12:48:05 評論於
Submitted on 21st November 2023, still "with editor" as of 23rd January 2024. No response received from editor after sending withdrawal email. It is recommended not to submit to this journal
(0) 讚! | MW小白

作者: 韦陀丽萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-17 23:44:38 評論於
Review speed: 3.0
Research focus: Review articles
Experience sharing in hematologic tumors: with editor
My submission has been in the "with editor" status for two and a half months, and then it was rejected directly, wasting three months of my time. Please be cautious when submitting
(0) 讚! | 韦陀丽萍

作者: 韦陀丽萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-12 18:43:37 評論於
I have reminded three times already
(0) 讚! | 韦陀丽萍

作者: 南川怀南


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-02 14:38:24 評論於
Is there any news now? I would like to have a reference
(0) 讚! | 南川怀南

作者: 韦陀丽萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-16 16:24:03 評論於
Heavy research direction: Overview; Blood cancer experience sharing: with editor for one month, two reminders, still no news, frustrating
(0) 讚! | 韦陀丽萍

作者: 南川怀南


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-12 19:38:23 評論於
Is there any follow-up to this? I would like to reference it, thank you
(0) 讚! | 南川怀南

作者: 法慧若曦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-10 13:46:01 評論於
On the second day
(0) 讚! | 法慧若曦

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*